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A B S T R A C T
Purpose: To compare subclinical balance dysfunction in patients with various epilepsy syndromes with
apparently healthy subjects.
Methods: Twenty-seven patients with localization-related epilepsy (LRE), 19 with primary generalized
epilepsy (PGE), who had no subjective complaints of impaired balance and no abnormal neurologic
ﬁndings on examination, and 22 apparently healthy subjects, underwent static posturography using the
Posture Scale Analyzer (PSA) system.
Results: Sway indexwas higher in patients compared to healthy subjects in all tests, signiﬁcant for single
leg stance (p = 0.005). Patients with PGE had a higher sway index compared to patients with LRE in six of
the tests, also signiﬁcant for single leg stance (p = 0.027). This difference was not affected by the type of
AED treatment or disease duration.
Conclusion: Posturography can improve balance function assessment in patients with epilepsy,
demonstrate subclinical impairment in seemingly asymptomatic patients, and further characterize
balance deﬁcits in different epilepsy syndromes.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Postural control is a complex neural function, composed of the
integrated function of sensory input, motor output, and modula-
tion by cerebellar and cognitive effects.1 Lack of coordination and
postural imbalance are common complaints in patients with
epilepsy (PWE), associated with motor limitations, injuries
secondary to seizures, and side effects of AEDs.2–4 Since the
neurological examination is often unremarkable and fails to detect
balance dysfunction, other tests may be required to qualitatively
and quantitatively assess balance dysfunction in these patients.
In PWE, subclinically impaired balance functionwas found to be
related mainly to treatment. Polytherapy,4 increased duration of
treatment with AED, certain speciﬁc AEDs2,3 and vagal nerve
stimulation5 were found to adversely affect postural stability.
However, the cognitive modulation of postural control can also be
affected by disease related factors, such as seizure type, age at
disease onset, seizure frequency, duration and severity of seizures,
seizure-related physiological dysfunction, structural cerebral* Corresponding author at: Department of Neurology, Assaf Harofeh Medical
Center, Zeriﬁn 70300, Israel. Tel.: +972 8 9778134; fax: +972 8 9779758.
E-mail address: revitalgm@hotmail.com (R. Gandelman-Marton).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.11.021damage caused by recurrent or prolonged seizures, and cerebral
lesions acquired prior to seizure onset.6
Only a few studies have assessed disease-related factors that
can affect balance. The results of static and dynamic balance tests
were similar in patients with partial or generalized seizures.7 In
another study, patients with localization-related epilepsy (LRE)
had increased body sway in several balance tests compared to
patients with primary generalized epilepsy (PGE), although the
difference was non signiﬁcant statistically.8
In the present study themain objective was the assessment of a
subclinical balance function in well deﬁned populations of
idiopathic PGE and LRE on AED treatment, in relation to normal
controls.
2. Methods
2.1. Study population
The study was approved by the institutional review board at the
Sheba Medical Center. Informed consent was obtained from all
patients andhealthy subjectswho agreed toparticipate in the study.
The population studied consisted of patients with PGE and LRE,
who were recruited consecutively from the epilepsy outpatient
clinic in the Sheba Medical Center from June 2008 until May 2009vier Ltd. All rights reserved.
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AEDs, as either mono- or polytherapy, at stable doses for at least
seven days prior to postural examination, and took their morning
dose prior to the clinic visit.
Patients were not included in the study if they had any of the
following:
1. Past medical history including a motor or balance disturbance
due to diseases involving the central or peripheral nervous
system, or due to orthopedic disorders, head or neck injuries,
peripheral vestibular disease, epilepsy-related operation, vagal
nerve stimulation, psychiatric diseases, malignancy, chronic
illnesses requiring chronic medical treatment that might affect
the nervous system, alcohol or drug addiction.
2. Motor or balance disturbance detected in the neurological
evaluation prior to the posturography.
3. Imaging with lesions in the brainstem, cerebellum, insula,
temporal neocortex, or in nuclei or tracts associated with motor
function, proprioception, vestibular or cerebellar systems.
4. Generalized, complex-partial or simple-partial seizures with a
motor component less than seven days prior to postural
examination.
5. Pregnancy.
6. Inability to sign the consent form or to complete the postural
examination.
The control subjects were recruited randomly and consisted
mainly of hospitalworkers and caregivers of the patients. All control
subjects were self-declared healthy persons, who were not taking
AEDs or any other medications that might affect their performance.
2.2. Data collection
Demographic datawere collected from themedical charts of the
patients in the outpatient clinic, and included age, gender, types of
seizures, the epilepsy syndrome, disease duration, results of brain
imaging, medications used and their dosing, co-morbidity and
additional medical treatments.
2.3. Equipment and protocol
The Posture Scale Analyzer (PSA, Gan-Ner, Israel) is a device
designed for the evaluation of static postural function. The PSA
consists of a simple force platform onwhich the subject stands and
a computer. The platform is divided into four compartments: leftTable 1
Characteristics of the study population.
PGE (n=19)
Age (years), mean SD 31.610.3
Male/female 5/14
BMI (kg/m2), mean SD 23.44.6
Dexterity – right foot dominant 18
Monotherapy/polytherapy 10/9
Epilepsy duration (years) 17.611.4
Antiepileptic drugs
n/dose (dose range)
Lamotrigine 16/319 (100–700)
Topiramate 4/106 (75–150)
Oxcarbazepine –
Levetiracetam 2/2250 (2000–2500)
Carbamazepine –
Valproic acid 6/1008 (500–2100)
Clobazam –
Phenobarbital 1/60
Clonazepam 2/1.13 (0.25–2)
Primidone –
n, number; BMI, body mass index; PGE, primary generalized epilepsy; LRE, localizationanterior, left posterior, right anterior, and right posterior. Under-
neath each compartment a compressive load cells is located, so
thatmeasuring and recording the normal forces, at a rate of 2 Hz, is
conducted simultaneously from the four load cells. The PSA
provides information on the weight distribution, the center of
pressure and the sway index (SI), deﬁned as the standard deviation
of the time and distance of the subject from the center of pressure.
The study was performed in all patients between 10 AM and
1 PM, after the epilepsy clinic visit, and consisted of seven tests for
postural assessment, each lasting 30 s: (1) standing still with eyes
open; (2) standing still with eyes closed; (3) standing still while
performing a cognitive challenge (Stroop test9); (4 and 5) standing
on one foot at a time, the right and then the left, with eyes open; and
(6 and 7) standing still with the eyes open while holding a 2 kg
weight in one hand, the right hand ﬁrst and then the left. Test 1 was
considered as the baseline. Test 2was performedwith eyes closed in
order to assess the proprioceptive component of balance function.
Standing on one foot (Tests 4 and 5) was chosen as a challenging
motor balance test condition. Tests 6 and 7 assessed the effect of the
deviation of the center of pressure on balance function.
Subjects were requested to stand as still and stable as possible
but to remain relaxed throughout the test, with the arms hanging
freely, and the feet apart at shoulder width. They were instructed
to look straight ahead at a target on the opposite wall. For Test 3,
the Stroop test board (30 cm  21 cm in size) was placed 1 m in
front of the subjects, and adequate vision was ascertained. The
examination took place in a quiet, well-lit room.
2.4. Statistical analysis
Statistical analysis was conducted using the SPSS version 15.0,
Chicago, IL. Natural logarithm transformation was performed due
to the skewed distribution of the SI. Pearson Chi-Square and
Fisher’s exact test were used to test categorical variables.
Continuous variables were analyzed by either t-test or analysis
of variance (ANOVA). Statistical signiﬁcance was set at p < 0.05.
3. Results
Demographic data, body mass index (BMI), type of AED
treatment, number of AEDs taken and mean dose are presented
in Table 1. There were no statistically signiﬁcant differences
between patients (PGE and LRE) and healthy subjects regarding
age, gender, BMI, and dexterity, neither between the two patientLRE (n=27) Controls (n=22) p value
38.211.8 37.411.6 0.127
10/17 10/12 0.448
22.73.5 24.64.1 0.27
21 21 0.536
13/14 – 0.5
1413.6 – 0.383
10/433 (200–800) –
6/175 (50–300) –
5/1025 (600–1800) –
6/1958 (750–3000) –
7/914 (200–1600) –
3/1025 (625–1250) –
1/30 –
1/115 –
1/0.25 –
1/625 –
related epilepsy. Dose is expressed in mg/day.
Table 2
Log SI (sway index) in patients with epilepsy and healthy subjects.
PGE (n=19) LRE (n=27) Controls (n=22)
Test 1 2.2 0.453 2.097 0.314 2.0710.299
Test 2 2.596 0.468 2.553 0.361 2.4320.358
Test 3 2.274 0.434 2.369 0.525 2.1460.462
Test 4 2.928 0.412* 2.662 0.292* 2.5440.283
Test 5 2.951 0.409** 2.915 0.522** 2.5310.325**
Test 6 2.076 0.47 2.072 0.457 1.9190.347
Test 7 2.058 0.397 2.054 0.345 1.9140.434
n, number; PGE, primary generalized epilepsy; LRE, localization related epilepsy.
* p=0.027 (PGE versus LRE).
** p=0.005 (PGE and LRE versus controls).
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small numbers of the various AEDs, no statistical analysis was
conducted for the individual drugs or for different dosages.
The SI results for each test in the two patient groups (PGE and
LRE) and the control subjects are presented in Table 2. In general,
the SIwas higher in the patients compared to healthy subjects in all
tests but signiﬁcance was reached only for Test 5 (p = 0.005).
Patients with PGE had a higher SI compared to patients with LRE in
six of the tests but signiﬁcant only for Test 4 (p = 0.027).
No correlationwas found between disease duration and balance
performance in the individual syndromes (PGE and LRE); however,
when both epilepsy syndrome groups were considered together,
their SI was signiﬁcantly correlated with disease duration in Test 5
(p = 0.013, r = 0.40).
4. Discussion
In this study, PWE had impaired balance function compared to
healthy subjects, signiﬁcant for single leg stance (left). Within the
epilepsy group, patients with PGE had a worse balance function
compared to patients with LRE, also signiﬁcant for single leg stance
(right). Even though the patients tested had no subjective balance
complaints, subtle subclinical balance disturbances could pose a
risk for falls and injuries.
Balance function in PWE was previously reported in only four
studies. Sirven et al.3 conducted a systematic evaluation of 16
randomized controlled trials that compared adjunctive therapy
with a second-generation AED versus placebo for partial epilepsy,
and reported dose-related rates of ataxia or imbalance. They found
that the imbalance risk is increased by the second-generation AEDs
at standard dosage, except for gabapentin and levetiracetam. Fife
et al.2 studied the balance function in 30 patients on monotherapy
for idiopathic partial or generalized epilepsy. Lamotrigine was
found to induce less disequilibrium compared to carbamazepine in
the modiﬁed Fregly ataxia battery, including the sharpened
Romberg position with eyes closed, standing on one leg with
eyes closed, and walking in tandem with arms folded and eyes
closed. There were no differences among patients treated with
carbamazepine, lamotrigine and gabapentin in the activities-
speciﬁc balance conﬁdence scale, the Berg balance scale and
computerized dynamic posturography. Petty et al.4 studied 29
twin and sibling pairs, discordant for AED exposure. Twenty-eight
of the AED users had epilepsy, including focal epilepsy in 14 and
generalized in 13. AED users had poorer balance function in the
Lord’s Coordinated Stability Test, the dynamic platform dual leg
stance condition and the dual and single leg stance conditions of
the static platform balance test, and the Activity Score. In addition,
AED polytherapy and increased duration of AED therapy were
found to be independent predictors of increased sway. Signiﬁcant
balance abnormalities were detected in the latter two studies and
in ours as well by the unilateral stance test, which was used in
order to challenge postural control due to the reduced base ofsupport and the additional alteration of the balance state by lifting
the non-stance leg forward. In all three studies, balance
impairment was attributed solely to factors related to AED
treatment, such as the type and number of AEDs and the duration
of treatment.
In a previous study that included evaluation of disease-related
factors, Gandelman-Marton et al.8 evaluated balance performance
by computerized dynamic platform posturography (CDPP) in 20
patients with epilepsy and ﬁve with a single seizure. The patients
were tested during admission following a generalized tonic–clonic
seizure, and none of the patients had a brain MRI. In addition to
polytherapy, the total number of seizures was found to signiﬁ-
cantly affect balance function. Patients who had more than two
seizures had a higher SI in all the balance tests, that included the
combinations of eyes closed, eyes open, stable and angularly
moving platform, and single-legged stance. The SI did not
signiﬁcantly differ between patients with PGE and LRE, although
there was a trend towards a signiﬁcantly higher SI in patients with
LRE compared to those with a single seizure in the single-legged
stance conditions.
In the present study, we included only PWE in the interictal
state, who had been free of seizures for a minimum of seven days.
Moreover, most of the patients with LRE in the present study had a
brainMRI. It is possible that if a brainMRIwas available in our prior
study, some of the PGE patients would have been reclassiﬁed as
having LRE, and this may have altered the inter-syndrome balance
function differences. It should be noted that the posturography
method in the present study was PSA, while the previous study8
employed CDPP.
The mechanisms underlying the increase in postural sway seen
in PWE are poorly understood. It can be assumed that in patients
with a normal neurological examination efferent and afferent
pathways involved in postural control are largely unaffected by
either treatment or disease-related factors. Cerebellar modulation
of postural control can be affected by several factors. Although
uncommon, vertigo may constitute an aura localized to the
posterior area of the superior temporal neocortex.10 In addition,
ataxia is a known consequence of status epilepticus and a common
side-effect of treatment with AEDs or vagal nerve stimula-
tion.5,11,12 However, if no balance impairment or cerebellar
abnormality can be detected by the neurological examination,
the more likely cause of postural deﬁcit can be related to abnormal
cognitive modulation. Cognitive ability can be inﬂuenced by the
etiology of seizures, such as focal brain lesion or progressive
cerebral degeneration.6 However, lower intellectual abilities were
also reported in patients with idiopathic generalized epilepsy
compared to the general population.13 Impairment in verbal and
visual memory, visuospatial tasks, some frontal functions, such as
mental ﬂexibility, concept formation, cognitive speed, working
memory, verbal ﬂuency, perseveration and planning, and a
widespread cognitive dysfunction outside the limits of the frontal
lobe were all demonstrated in patients with juvenile myoclonic
epilepsy.14 This deﬁcit in cognitive modulation can account for the
worse balance function we found in patient with PGE compared to
those with LRE.
Our study population was relatively large and age-matched to
the controls. All the patients were on AED treatment and in the
interictal state, and none of them had anatomic structural lesions.
However, this study has several limitations. Since the patients
were recruited during a routine visit in the outpatient clinic, it was
practically impossible to perform the posturography at a ﬁxed
interval from the last AED dose. In addition, we did not obtain AED
blood levels on the day of the test, since the blood levels of the
AEDs taken by most patients could not be routinely measured.
The identiﬁcation of a subclinical balance dysfunction in our
patients provides an additional support to the hypothesis that
G. Yahalom et al. / Seizure 20 (2011) 214–217 217patients with epilepsy do have balance dysfunction even if on
direct questioning they claim to be asymptomatic. Our results
support previous studies suggesting that posturography can
improve the evaluation of balance function in epilepsy patients,
and allows further characterization of balance function in different
epilepsy syndromes. By highlighting subtle balance impairment
and risk of falls in PWE, our ﬁndingsmay have an impact on patient
safety and quality of life.
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